Literature DB >> 2320378

Humoral immune responses of Hereford cattle vaccinated with midgut antigens of the cattle tick, Boophilus microplus.

L A Jackson1, J P Opdebeeck.   

Abstract

Vaccination of cattle with midgut membrane (GM) antigen derived from the cattle tick, Boophilus microplus, infected with the adjuvant Quil A, resulted in significant increases in total immunoglobulins, mainly in the IgG1 and IgG2 fractions of the serum. Analysis of the anti-GM antibody levels of vaccinated cattle showed that the levels of IgG, IgG1 and complement-fixing antibodies were significantly correlated to protection against infestation with cattle ticks. Anti-GM antibodies of the IgG2 and IgM isotype were not correlated to protection against infestation with cattle ticks. Anti-GM antibodies fixed complement (C') in the presence of GM, larval membrane antigen and live, midgut cells, but not in the presence of live, larval cells. Anti-GM antibodies were able to fix C' equally well in the presence of GM antigen and live, midgut cells. None of the antigens tested activated the alternate pathway of complement under the conditions tested. Levels of anti-GM IgG1 antibodies were used to develop a regression model for predicting levels of protection against infestation with cattle ticks in vaccinated cattle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2320378     DOI: 10.1111/j.1365-3024.1990.tb00943.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  2 in total

1.  Isolation of protective antigens from the gut of Boophilus microplus using monoclonal antibodies.

Authors:  R P Lee; J P Opdebeeck
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

2.  The evaluation of yeast derivatives as adjuvants for the immune response to the Bm86 antigen in cattle.

Authors:  M Rodríguez Valle; C Montero; H Machado; M Joglar; J de la Fuente; J C Garcia-Garcia
Journal:  BMC Biotechnol       Date:  2001-05-24       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.